Glimefion®
Glimepiride
Indication : Glimefion® is indicated for
– Patients with Noninsulin-Dependent (Type II) Diabetes Mellitus (NIDDM) whose hyperglycemia cannot be controlled by diet and exercise alone.
– Adjunct to diet and exercise to reduce the blood glucose.
Glimepiride can be combined with insulin, but this combination may increase the potential for hypoglycemia.
Composition :
Each Glimefion® Tablet 1 mg contains Glimepiride 1 mg.
Each Glimefion® Tablet 2 mg contains Glimepiride 2 mg.
Each Glimefion® Tablet 3 mg contains Glimepiride 3 mg.
Each Glimefion® Tablet 4 mg contains Glimepiride 4 mg.
Presentation :
Glimefion® Tablet 1 mg
Box, 3 blisters @ 10 tablets
Glimefion® Tablet 2 mg
Box, 3 blisters @ 10 tablets
Glimefion® Tablet 3 mg
Box, 3 blisters @ 10 tablets
Glimefion® Tablet 4 mg
Box, 3 blisters @ 10 tablets
On medical prescription only.
Store below 30°C.